Measuring melatonin in humans

Susan Benloucif, Helen J. Burgess, Elizabeth B. Klerman, Alfred Lewy, Benita Middleton, Patricia J. Murphy, Barbara L. Parry, Victoria L. Revell

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

Study Objectives: To provide guidelines for collecting and analyzing urinary, salivary, and plasma melatonin, thereby assisting clinicians and researchers in determining which method of measuring melatonin is most appropriate for their particular needs and facilitating the comparison of data between laboratories. Methods: A modified RAND process was utilized to derive recommendations for methods of measuring melatonin in humans. Results: Consensus-based guidelines are presented for collecting and analyzing melatonin for studies that are conducted in the natural living environment, the clinical setting, and in-patient research facilities under controlled conditions. Conclusions: The benefits and disadvantages of current methods of collecting and analyzing melatonin are summarized. Although a single method of analysis would be the most effective way to compare studies, limitations of current methods preclude this possibility. Given that the best analysis method for use under multiple conditions is not established, it is recommended to include, in any published report, one of the established low threshold measures of dim light melatonin onset to facilitate comparison between studies.

Original languageEnglish (US)
Pages (from-to)66-69
Number of pages4
JournalJournal of Clinical Sleep Medicine
Volume4
Issue number1
StatePublished - Feb 15 2008

Fingerprint

Melatonin
Guidelines
Research Personnel
Light
Research

Keywords

  • 6-sulphatoxymelatonin
  • DLMO
  • Plasma melatonin
  • Salivary melatonin

ASJC Scopus subject areas

  • Clinical Neurology
  • Pulmonary and Respiratory Medicine
  • Neurology

Cite this

Benloucif, S., Burgess, H. J., Klerman, E. B., Lewy, A., Middleton, B., Murphy, P. J., ... Revell, V. L. (2008). Measuring melatonin in humans. Journal of Clinical Sleep Medicine, 4(1), 66-69.

Measuring melatonin in humans. / Benloucif, Susan; Burgess, Helen J.; Klerman, Elizabeth B.; Lewy, Alfred; Middleton, Benita; Murphy, Patricia J.; Parry, Barbara L.; Revell, Victoria L.

In: Journal of Clinical Sleep Medicine, Vol. 4, No. 1, 15.02.2008, p. 66-69.

Research output: Contribution to journalArticle

Benloucif, S, Burgess, HJ, Klerman, EB, Lewy, A, Middleton, B, Murphy, PJ, Parry, BL & Revell, VL 2008, 'Measuring melatonin in humans', Journal of Clinical Sleep Medicine, vol. 4, no. 1, pp. 66-69.
Benloucif S, Burgess HJ, Klerman EB, Lewy A, Middleton B, Murphy PJ et al. Measuring melatonin in humans. Journal of Clinical Sleep Medicine. 2008 Feb 15;4(1):66-69.
Benloucif, Susan ; Burgess, Helen J. ; Klerman, Elizabeth B. ; Lewy, Alfred ; Middleton, Benita ; Murphy, Patricia J. ; Parry, Barbara L. ; Revell, Victoria L. / Measuring melatonin in humans. In: Journal of Clinical Sleep Medicine. 2008 ; Vol. 4, No. 1. pp. 66-69.
@article{f9204b992c7d43768ad7215d4595c412,
title = "Measuring melatonin in humans",
abstract = "Study Objectives: To provide guidelines for collecting and analyzing urinary, salivary, and plasma melatonin, thereby assisting clinicians and researchers in determining which method of measuring melatonin is most appropriate for their particular needs and facilitating the comparison of data between laboratories. Methods: A modified RAND process was utilized to derive recommendations for methods of measuring melatonin in humans. Results: Consensus-based guidelines are presented for collecting and analyzing melatonin for studies that are conducted in the natural living environment, the clinical setting, and in-patient research facilities under controlled conditions. Conclusions: The benefits and disadvantages of current methods of collecting and analyzing melatonin are summarized. Although a single method of analysis would be the most effective way to compare studies, limitations of current methods preclude this possibility. Given that the best analysis method for use under multiple conditions is not established, it is recommended to include, in any published report, one of the established low threshold measures of dim light melatonin onset to facilitate comparison between studies.",
keywords = "6-sulphatoxymelatonin, DLMO, Plasma melatonin, Salivary melatonin",
author = "Susan Benloucif and Burgess, {Helen J.} and Klerman, {Elizabeth B.} and Alfred Lewy and Benita Middleton and Murphy, {Patricia J.} and Parry, {Barbara L.} and Revell, {Victoria L.}",
year = "2008",
month = "2",
day = "15",
language = "English (US)",
volume = "4",
pages = "66--69",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "1",

}

TY - JOUR

T1 - Measuring melatonin in humans

AU - Benloucif, Susan

AU - Burgess, Helen J.

AU - Klerman, Elizabeth B.

AU - Lewy, Alfred

AU - Middleton, Benita

AU - Murphy, Patricia J.

AU - Parry, Barbara L.

AU - Revell, Victoria L.

PY - 2008/2/15

Y1 - 2008/2/15

N2 - Study Objectives: To provide guidelines for collecting and analyzing urinary, salivary, and plasma melatonin, thereby assisting clinicians and researchers in determining which method of measuring melatonin is most appropriate for their particular needs and facilitating the comparison of data between laboratories. Methods: A modified RAND process was utilized to derive recommendations for methods of measuring melatonin in humans. Results: Consensus-based guidelines are presented for collecting and analyzing melatonin for studies that are conducted in the natural living environment, the clinical setting, and in-patient research facilities under controlled conditions. Conclusions: The benefits and disadvantages of current methods of collecting and analyzing melatonin are summarized. Although a single method of analysis would be the most effective way to compare studies, limitations of current methods preclude this possibility. Given that the best analysis method for use under multiple conditions is not established, it is recommended to include, in any published report, one of the established low threshold measures of dim light melatonin onset to facilitate comparison between studies.

AB - Study Objectives: To provide guidelines for collecting and analyzing urinary, salivary, and plasma melatonin, thereby assisting clinicians and researchers in determining which method of measuring melatonin is most appropriate for their particular needs and facilitating the comparison of data between laboratories. Methods: A modified RAND process was utilized to derive recommendations for methods of measuring melatonin in humans. Results: Consensus-based guidelines are presented for collecting and analyzing melatonin for studies that are conducted in the natural living environment, the clinical setting, and in-patient research facilities under controlled conditions. Conclusions: The benefits and disadvantages of current methods of collecting and analyzing melatonin are summarized. Although a single method of analysis would be the most effective way to compare studies, limitations of current methods preclude this possibility. Given that the best analysis method for use under multiple conditions is not established, it is recommended to include, in any published report, one of the established low threshold measures of dim light melatonin onset to facilitate comparison between studies.

KW - 6-sulphatoxymelatonin

KW - DLMO

KW - Plasma melatonin

KW - Salivary melatonin

UR - http://www.scopus.com/inward/record.url?scp=43549120513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549120513&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 66

EP - 69

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 1

ER -